We started following NYER in November last year (see the initial post) when the stock was trading at $ 1.75, and NYER had announced
the liquidation subject to the approval of its shareholders and the closing of two transactions.
As previously disclosed on October 23, 2009, in conjunction with the sale of a substantial portion of the assets of D.A.W., Inc. («DAW»), a wholly owned subsidiary of Nyer Medical Group, Inc. («Nyer»),
to Walgreen Easter Co. (the «WAG Transaction) and the sale of the stock of DAW
to certain management investors (the «DAW Stock Transaction»), the Board of Directors of Nyer approved the
liquidation and dissolution of Nyer pursuant
to a Plan of Dissolution (the «Plan of Dissolution»),
subject to obtaining shareholder
approval of the WAG Transaction, the DAW Stock Transaction, and the Plan of Dissolution (the «Transactions»).